Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,549 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Los Angeles CA, Orange CA, Irvine CA, Fresno CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase2, Recruiting

Wound Irrigation With Saline Versus Hypodilute-chlorhexidine After Cesarean Section (WISHES Study)

for
Cesarean Section Complications, Cesarean Section; Infection
Location: Loma Linda CA
Sponsor: Loma Linda University

Sex: Female

Age: 18+

Code: NCT06339203

Recruiting

Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy

for
Radiation Therapy
Location: Los Angeles CA, Duarte CA
Sponsor: DxTerity Diagnostics

Sex: All

Age: 18+

Code: NCT03142425

Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Los Angeles CA, South Pasadena CA, Bellflower CA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04269902

Phase3, Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Los Angeles CA, San Diego CA, Palo Alto CA, Phoenix AZ,
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT05911568

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

for
Severe Combined Immunodeficiency, X Linked, Gene Therapy
Location: Los Angeles CA, Cincinnati OH, Atlanta GA, Boston MA
Sponsor: David Williams

Sex: Male

Age: 0 - 5

Code: NCT03311503

Phase1, Phase2, Recruiting

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

for
Ischemic Stroke, Intracerebral Hemorrhage,
Location: Los Angeles CA, San Diego CA, Phoenix AZ,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT04916210

Recruiting

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

for
Lymphatic Malformations
Location: Orange CA, Palo Alto CA, Oakland CA, Portland OR,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 0 - 70+

Code: NCT05948943

Phase2, Phase3, Recruiting

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

for
Acute Stroke, Ischemic Stroke, Stroke
Location: Los Angeles CA, Glendale CA, Arcadia CA, Torrance CA,
Sponsor: DiaMedica Therapeutics Inc

Sex: All

Age: 18 - 70+

Code: NCT05065216

Phase2, Phase3, Recruiting

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

for
Cancer Pain, Visceral Pain, Gastrointestinal Neoplasms,
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18 - 70+

Code: NCT04907643

Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Beverly Hills CA, Bellflower CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase2, Phase3, Recruiting

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

for
Hemolytic Disease of the Fetus and Newborn
Location: Los Angeles CA, La Jolla CA, Sacramento CA, Murray UT,
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18 - 45

Code: NCT05912517

Phase3, Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for
Dravet Syndrome
Location: Orange CA, San Francisco CA, Salt Lake City UT,
Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase3, Recruiting

A Study to Prevent Infantile Spasms Relapse

for
Infantile Spasms, Infantile Epileptic Spasms Syndrome,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 0 - 1

Code: NCT06819670

Phase2, Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Cancer, Metastatic Cancer,
Location: Los Angeles CA, West Valley City UT, Portland OR,
Sponsor: MacroGenics

Sex: All

Age: 18+

Code: NCT06242470

Phase1, Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for
Acral Lentiginous Melanoma,
Location: Burbank CA, Los Angeles CA, San Diego CA, Dublin CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase2, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

for
Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
Location: Los Angeles CA, Santa Monica CA, Duarte CA, Orange CA,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06858813

Phase1, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Pasadena CA, Encino CA, Fountain Valley CA,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for
Locally Advanced Breast Cancer, Unresectable Breast Carcinoma,
Location: Beverly Hills CA, Newport Beach CA, Vancouver,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06827236

Phase1, Phase2, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Los Angeles CA, Beverly Hills CA, Torrance CA,
Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase3, Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles